These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23123013)

  • 21. Pseudo-chaotic oscillations in CRISPR-virus coevolution predicted by bifurcation analysis.
    Berezovskaya FS; Wolf YI; Koonin EV; Karev GP
    Biol Direct; 2014 Jul; 9():13. PubMed ID: 24986220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CRISPR system: small RNA-guided defense in bacteria and archaea.
    Karginov FV; Hannon GJ
    Mol Cell; 2010 Jan; 37(1):7-19. PubMed ID: 20129051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The functional aspects of bacterial CRISPR-cas systems and interactions between phages and its bacterial hosts--a review].
    Fu Q; Sun J; Yan Y
    Wei Sheng Wu Xue Bao; 2015 Mar; 55(3):251-7. PubMed ID: 26065266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in clustered regularly interspaced short palindromic repeats--a review].
    Wang L; He J; Wang J
    Wei Sheng Wu Xue Bao; 2011 Aug; 51(8):1007-13. PubMed ID: 22097765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial Arsenal of Antiviral Defenses. Part II.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus population dynamics and acquired virus resistance in natural microbial communities.
    Andersson AF; Banfield JF
    Science; 2008 May; 320(5879):1047-50. PubMed ID: 18497291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas: Adapting to change.
    Jackson SA; McKenzie RE; Fagerlund RD; Kieper SN; Fineran PC; Brouns SJ
    Science; 2017 Apr; 356(6333):. PubMed ID: 28385959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon.
    Manica A; Zebec Z; Teichmann D; Schleper C
    Mol Microbiol; 2011 Apr; 80(2):481-91. PubMed ID: 21385233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The size of the immune repertoire of bacteria.
    Bradde S; Nourmohammad A; Goyal S; Balasubramanian V
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5144-5151. PubMed ID: 32071241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial Arsenal of Antiviral Defenses - Part I.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconclusive studies on possible CRISPR-Cas off-targets should moderate expectations about enzymes that have evolved to be non-specific.
    Chakraborty S
    J Biosci; 2018 Jun; 43(2):225-228. PubMed ID: 29872009
    [No Abstract]   [Full Text] [Related]  

  • 32. The CRISPR-Cas immune system: biology, mechanisms and applications.
    Rath D; Amlinger L; Rath A; Lundgren M
    Biochimie; 2015 Oct; 117():119-28. PubMed ID: 25868999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-canonical inhibition strategies and structural basis of anti-CRISPR proteins targeting type I CRISPR-Cas systems.
    Yin P; Zhang Y; Yang L; Feng Y
    J Mol Biol; 2023 Apr; 435(7):167996. PubMed ID: 36754343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene regulation by engineered CRISPR-Cas systems.
    Fineran PC; Dy RL
    Curr Opin Microbiol; 2014 Apr; 18():83-9. PubMed ID: 24637219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host diversity limits the evolution of parasite local adaptation.
    Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S
    Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria.
    Chakraborty S; Snijders AP; Chakravorty R; Ahmed M; Tarek AM; Hossain MA
    Mol Phylogenet Evol; 2010 Sep; 56(3):878-87. PubMed ID: 20580935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS.
    Pul U; Wurm R; Arslan Z; Geissen R; Hofmann N; Wagner R
    Mol Microbiol; 2010 Mar; 75(6):1495-512. PubMed ID: 20132443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of CRISPR loci in lactic acid bacteria genomes.
    Horvath P; Coûté-Monvoisin AC; Romero DA; Boyaval P; Fremaux C; Barrangou R
    Int J Food Microbiol; 2009 Apr; 131(1):62-70. PubMed ID: 18635282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Archaeal CRISPR-based immune systems: exchangeable functional modules.
    Garrett RA; Vestergaard G; Shah SA
    Trends Microbiol; 2011 Nov; 19(11):549-56. PubMed ID: 21945420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system.
    Han P; Niestemski LR; Barrick JE; Deem MW
    Phys Biol; 2013 Apr; 10(2):025004. PubMed ID: 23492852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.